Mirum Pharmaceuticals, Inc. Capital Expenditures
Mirum Pharmaceuticals, Inc. (MIRM) reported Capital Expenditures of $687.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-05
- Mirum Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $23.00K, a 81.75% decline year-over-year.
- Mirum Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $664.00K, a 1519.51% increase year-over-year.
- Mirum Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $600.00K, a 2900.00% increase year-over-year.
- Mirum Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $187.00K, a 3.31% increase year-over-year.
- Mirum Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $954.00K, a 3.93% decline from fiscal 2024.
- Mirum Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $993.00K, a 811.01% increase from fiscal 2023.
- Mirum Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $109.00K, a 60.79% decline from fiscal 2022.
- Mirum Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $278.00K, a 1058.33% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 8 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $687.00K 10-Q · filed 2026-08-05 | $1.29M derived: sum of 3 quarters · filed 2026-08-05 | $1.47M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | $664.00K 10-Q · filed 2026-05-06 | $1.26M derived: sum of 2 quarters · filed 2026-05-06 | $1.45M derived: sum of 3 quarters · filed 2026-05-06 | $1.58M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $787.00K derived: sum of 2 quarters · filed 2026-02-25 | $913.00K derived: sum of 3 quarters · filed 2026-08-05 | $954.00K 10-K · filed 2026-02-25 | |
| 2025-09-30 | $187.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $313.00K derived: sum of 2 quarters · filed 2026-08-05 | $354.00K 10-Q · filed 2025-11-04 | $374.00K derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $126.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $167.00K 10-Q · filed 2026-08-05 | $187.00K derived: sum of 3 quarters · filed 2026-08-05 | $368.00K derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $41.00K 10-Q · filed 2026-05-06 | $61.00K derived: sum of 2 quarters · filed 2026-05-06 | $242.00K derived: sum of 3 quarters · filed 2026-05-06 | $1.02M derived: sum of 4 quarters · filed 2026-05-06 | |
| 2024-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $201.00K derived: sum of 2 quarters · filed 2026-02-25 | $980.00K derived: sum of 3 quarters · filed 2026-02-25 | $993.00K 10-K · filed 2026-02-25 | |
| 2024-09-30 | $181.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $960.00K derived: sum of 2 quarters · filed 2025-11-04 | $973.00K 10-Q · filed 2025-11-04 | $973.00K derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-06-30 | $779.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $792.00K 10-Q · filed 2025-08-06 | $792.00K derived: sum of 3 quarters · filed 2026-02-25 | $792.00K derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-03-31 | $13.00K 10-Q · filed 2025-05-07 | $13.00K derived: sum of 2 quarters · filed 2026-02-25 | $13.00K derived: sum of 3 quarters · filed 2026-02-25 | $81.00K derived: sum of 4 quarters · filed 2026-02-25 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $68.00K derived: sum of 3 quarters · filed 2026-02-25 | $109.00K 10-K · filed 2026-02-25 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $68.00K derived: sum of 2 quarters · filed 2024-11-12 | $109.00K 10-Q · filed 2024-11-12 | $351.00K derived: sum of 4 quarters · filed 2025-02-26 | |
| 2023-06-30 | $68.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $109.00K 10-Q · filed 2024-08-07 | $351.00K derived: sum of 3 quarters · filed 2025-02-26 | $370.00K derived: sum of 4 quarters · filed 2025-02-26 | |
| 2023-03-31 | $41.00K 10-Q · filed 2024-05-08 | $283.00K derived: sum of 2 quarters · filed 2025-02-26 | $302.00K derived: sum of 3 quarters · filed 2025-02-26 | $319.00K derived: sum of 4 quarters · filed 2025-02-26 | |
| 2022-12-31 | $242.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $261.00K derived: sum of 2 quarters · filed 2025-02-26 | $278.00K derived: sum of 3 quarters · filed 2025-02-26 | $278.00K 10-K · filed 2025-02-26 | |
| 2022-09-30 | $19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $36.00K derived: sum of 2 quarters · filed 2023-11-02 | $36.00K 10-Q · filed 2023-11-02 | $39.00K derived: sum of 4 quarters · filed 2024-03-15 | |
| 2022-06-30 | $17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $17.00K 10-Q · filed 2023-08-07 | $20.00K derived: sum of 3 quarters · filed 2024-03-15 | $38.00K derived: sum of 4 quarters · filed 2024-03-15 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-04 | $3.00K derived: sum of 2 quarters · filed 2024-03-15 | $21.00K derived: sum of 3 quarters · filed 2024-03-15 | $21.00K derived: sum of 4 quarters · filed 2024-03-15 | |
| 2021-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $21.00K derived: sum of 2 quarters · filed 2024-03-15 | $21.00K derived: sum of 3 quarters · filed 2024-03-15 | $24.00K 10-K · filed 2024-03-15 | |
| 2021-09-30 | $18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $18.00K derived: sum of 2 quarters · filed 2022-11-09 | $21.00K 10-Q · filed 2022-11-09 | $49.00K derived: sum of 4 quarters · filed 2022-11-09 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $3.00K 10-Q · filed 2022-08-04 | $31.00K derived: sum of 3 quarters · filed 2022-08-04 | $77.00K derived: sum of 4 quarters · filed 2022-08-04 | |
| 2021-03-31 | $3.00K 10-Q · filed 2022-05-05 | $31.00K derived: sum of 2 quarters · filed 2022-05-05 | $77.00K derived: sum of 3 quarters · filed 2022-05-05 | $130.00K derived: sum of 4 quarters · filed 2022-05-05 | |
| 2020-12-31 | $28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $74.00K derived: sum of 2 quarters · filed 2022-03-09 | $127.00K derived: sum of 3 quarters · filed 2022-03-09 | $225.00K 10-K · filed 2022-03-09 | |
| 2020-09-30 | $46.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $99.00K derived: sum of 2 quarters · filed 2021-11-15 | $197.00K 10-Q · filed 2021-11-15 | $264.00K derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | $53.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $151.00K 10-Q · filed 2021-08-05 | $218.00K derived: sum of 3 quarters · filed 2021-08-05 | $388.00K derived: sum of 4 quarters · filed 2021-08-05 | |
| 2020-03-31 | $98.00K 10-Q · filed 2021-05-06 | $165.00K derived: sum of 2 quarters · filed 2021-05-06 | $335.00K derived: sum of 3 quarters · filed 2021-05-06 | $335.00K derived: sum of 4 quarters · filed 2021-05-06 | |
| 2019-12-31 | $67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $237.00K derived: sum of 2 quarters · filed 2021-03-09 | $237.00K derived: sum of 3 quarters · filed 2021-03-09 | $281.00K 10-K · filed 2021-03-09 | |
| 2019-09-30 | $170.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $170.00K derived: sum of 2 quarters · filed 2020-11-12 | $214.00K 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $44.00K 10-Q · filed 2020-08-06 | |||
| 2019-03-31 | $44.00K 10-Q · filed 2020-05-07 | ||||
| 2018-12-31 | $0.00 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |